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Mitochondrial aconitase is sensitive to oxidative inactivation and can aggregate and accumulate in many age-related
disorders. Here we report that Lon protease, an ATP-stimulated mitochondrial matrix protein, selectively recognizes
and degrades the oxidized, hydrophobic form of aconitase after mild oxidative modification, but that severe oxidation
results in aconitase aggregation, which makes it a poor substrate for Lon. Similarly, a morpholino oligodeoxynu-
cleotide directed against the lon gene markedly decreases the amount of Lon protein, Lon activity and aconitase
degradation in WI-38 VA-13 human lung fibroblasts and causes accumulation of oxidatively modified aconitase. The
ATP-stimulated Lon protease may be an essential defence against the stress of life in an oxygen environment. By
recognizing minor oxidative changes to protein structure and rapidly degrading the mildly modified protein, Lon
protease may prevent extensive oxidation, aggregation and accumulation of aconitase, which could otherwise
compromise mitochondrial function and cellular viability. Aconitase is probably only one of many mitochondrial
matrix proteins that are preferentially degraded by Lon protease after oxidative modification.
The selective removal of oxidatively modified proteins by prote-olytic digestion is an important component of cellular defencesagainst oxidative stress1,2. In the mammalian cell cytoplasm,
nucleus and endoplasmic reticulum, the proteasome complex car-
ries out this important function3–7. Although neither bacteria nor
mammalian mitochondria express the proteasome, both can selec-
tively degrade oxidatively damaged internal proteins8–11.
The mitochondrial electron transport chain is probably the main
source of intracellular free radicals1,10,12–16, and mitochondrial pro-
teins are highly subject to oxidative modification and inactiva-
tion1,14,16–19. Although various proteolytic systems have been identi-
fied in different mitochondrial compartments20, the turnover of
both normal and oxidatively modified mitochondrial proteins is
understood poorly.
The ATP-stimulated proteolysis of caseine has been measured in
the mitochondrial matrix from many different mammalian tis-
sues21–26. The enzyme responsible was identified as the mammalian
Lon protease22,25,26, a homologue of bacterial protease La21,27 and
yeast PIM1 protease28. Yeast strains lacking a functional pim1 gene
have impaired ability to degrade mitochondrial matrix proteins28
and to maintain functional mitochondrial DNA29,30.
Aconitase, an essential mitochondrial enzyme, is particularly
susceptible to oxidative damage31,32 and is preferentially oxidatively
modified and inactivated during ageing. Previous results have
shown that mammalian mitochondria contain a proteolytic system
that can recognize and degrade various oxidatively denatured pro-
teins in vitro10,11. Here we have examined whether Lon protease is
responsible for the degradation of both oxidized and native aconi-
tase in bovine and human mitochondria, and whether downregula-
tion of lon expression results in the accumulation of aconitase.
Results
Modification of aconitase by treatment with H2O2. The enzymatic
activity of aconitase was decreased by treatment with H2O2
(Fig. 1a), but no simple relationship between activity and H2O2
concentration was observed. No substantial loss of aconitase activ-
ity occurred at H2O2 concentrations below 2 mM. Enzymatic activ-
ity decreased by 50% after treatment with 5 mM H2O2, but there
was still 33% residual aconitase activity after incubation with
20 mM H2O2. Oxidation by even the lowest concentrations of H2O2
caused immediate and large increases in the overall hydrophobici-
ty of aconitase, as measured by hydrophobic interaction chro-
matography (Fig. 1a). We have seen a similar oxidation-induced
partial denaturation, followed by the exposure of hydrophobic
‘patches’ of (normally internally shielded) amino acids, in several
other proteins1,3,33.
Aggregation of aconitase was negligible at exposure to low con-
centrations of H2O2, but increased exponentially at H2O2 concen-
trations above 5 mM (Fig. 1a). Western blot analysis of the treated
enzyme (Fig. 1b) showed bands migrating with a relative molecu-
lar mass (Mr) higher than 80,000 (80K) in SDS polyacrylamide gel
electrophoresis (SDS–PAGE), indicating that substantial protein
aggregation occurred at H2O2 concentrations as low as 2 mM. At
5 mM H2O2, both aggregation and protein fragmentation, as
judged by an SDS–PAGE band at about 40K, occurred. Clearly, a
significant proportion of the aconitase aggregation seen in Fig. 1a
was noncovalent, because most of the aggregates were disrupted by
SDS–PAGE. Finally, partial loss of antigenicity (loss of band densi-
ty) was observed at the highest concentration of 20 mM H2O2, indi-
cating that extreme oxidative modification of the protein had
occurred.
A mitochondrial proteolytic system preferentially degrades oxi-
dized aconitase. The proteolytic susceptibility of aconitase, when
incubated with extracts of beef heart mitochondria, increased rapid-
ly after in vitro treatment with H2O2 up to a concentration of 5 mM
(Fig. 2a). At this exposure to oxidant, the rate of aconitase degrada-
tion was seven times higher than the breakdown of unoxidized
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aconitase. When aconitase was subjected to higher concentrations
of H2O2, its proteolytic susceptibility actually decreased, and it
returned to basal levels after treatment with 20 mM H2O2.
A comparison of Figs 1a, b and 2a shows that mildly oxidized
aconitase is a good proteolytic substrate, whereas extreme oxidative
modification of aconitase results in a loss of proteolytic suscepti-
bility. We propose that the exposure of hydrophobic patches in
mildly oxidized aconitase makes it a better proteolytic substrate,
whereas increasing aggregation at higher H2O2 concentrations (Fig.
1) makes aconitase a progressively poorer proteolytic substrate
(Fig. 2a). This interpretation is very much in agreement with our
studies of the degradation of other oxidized proteins (and aconitase
itself) by other proteases1,3,6,9,32–34.
When ATP was added to the reaction mixture, the degradation
of aconitase increased 2–4-fold, depending on the oxidation status
of the substrate. We used 5 mM H2O2 treated (oxidized) aconitase—
the substrate that achieved maximal degradation by the bovine
heart mitochondrial extract—as a model substrate in subsequent
studies and compared it with control (untreated) aconitase. With
both substrates, the rate of proteolytic degradation was linear for
the first 60 min and reached a plateau after 90 min (Fig. 2b).
To ensure that proteases in the mitochondrial extracts could not
have been inhibited by any residual H2O2 (possibly remaining even
after dialysis), we added increasing concentrations of H2O2 to a
maximum of 20 mM to tubes containing buffer only and then dial-
ysed the samples (as for Fig. 2a). These dialysed buffer samples
were then added to mitochondrial extracts containing heat dena-
tured [3H]aconitase, which is an excellent substrate for proteolysis.
Regardless of the initial H2O2 concentration before dialysis, these
dialysed buffer samples had no measurable effect on mitochondri-
al extract proteolytic activity in the presence or absence of ATP,
indicating that dialysis was very effective in removing H2O2 (data
not shown).
Mitochondrial aconitase is degraded by an ATP-stimulated serine
protease. Inhibitory trials, designed to characterize the proteolytic
activity that selectively degrades oxidized aconitase, suggested that
an ATP-stimulated serine protease may be involved (Table 1).
Degradation of both oxidized and unoxidized aconitase was
strongly inhibited by phenylmethylsulfonyl floride (PMSF), a ser-
ine protease inhibitor, and partially inhibited by N-ethylmaleimide
(NEM), a cysteine protease inhibitor. Addition of ATP stimulated
the proteolysis of oxidized and control substrates by about the same
percentage (in the presence of 5 mM ATP the activity was increased
2–3.5-fold). EDTA decreased proteolytic activity in the absence of
ATP only slightly, but blocked the ATP-stimulated portion of pro-
tein degradation much more effectively. NLVS, a recognized pro-
teosome inhibitor, had no effect on degradation, thus excluding the
Table 1 Inhibitors of ATP-dependent aconitase degradation (% inhibition)
Aconitase Oxidized aconitase
no ATP 5 mM ATP no ATP 5 mM ATP
EDTA 11% 40% 30% 57%
PMSF 100% 83% 48% 75%
NEM 56% 64% 20% 45%
NLVS 0% 0% 0% 0%
Protein degradation was measured (see Fig. 2a) in the presence or absence of ATP
(5 mM). The inhibitors EDTA (25 mM), PMSF (5 mM), NEM (1 mM) and NLVS (20 µM) were
added as indicated. The uninhibited, absolute values for degradation of oxidized and con-
trol aconitase, both with and without ATP, are given in Table 2. Each value represents the
mean of six independent determinations, for which the standard errors were always less
than 10%.
Table 2 Proteolytic degradation of aconitase by mitochondrial
extract and purified Lon protease 
Aconitase Oxidized aconitase
no ATP 5 mM ATP no ATP 5 mM ATP
Mitochondrial extract 0.2 1.0 1.8 3.6
Purified Lon Protease 91.5 327.5 574.0 1950.0
Values are in micrograms of degraded protein per milligram of mitochondrial extract pro-
tein or Lon protease protein per hour. Proteolytic specific activity was measured for the
mitochondrial matrix fraction and for purified Lon protease against dialysed control and oxi-
dized aconitase. Each value represents the mean of nine independent determinations for
which the standards errors were always less than 10%.
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Figure 1 Loss of aconitase activity and protein modification after H2O2 treat-
ment. Aconitase (0.33 mg ml−1) was incubated with H2O2 at the concentrations indi-
cated for 30 min at 37 °C. Residual peroxide was removed by dialysis, and both
oxidized and control aconitase were studied. a, Effect of H2O2 on aconitase activity,
reported as a percentage of the control activity, and on the hydrophobicity of the
[3H]aconitase protein, measured by butyl-Sepharose 4B hydrophobic interaction
chromatography33 and reported as the elution volume of [3H]aconitase from the col-
umn in millilitres. Also shown is the overall aconitase aggregation measured by the
percentage of total [3H]aconitase (Mr ≈ 83K) retained by the 100,000 nominal
molecular mass cut-off Ultracel membrane of a Centricon (Millipore) centrifugal fil-
ter. b, Western blot study of untreated aconitase and aconitase exposed to various
concentrations of H2O2. Results in a are the means and standard errors of six inde-
pendent determinations, and the blot shown in b was repeated several times with
similar results. 
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possibility of proteasome contamination. Limited experiments sug-
gested that Lactacystin, another proteasome inhibitor, might also
inhibit mitochondrial proteolysis (data not shown), but in a non-
specific manner similar to the inhibition of lysosomal proteolysis
by the same reagent35.
Although ATP strongly stimulated degradation, ADP only pro-
duced a mild increase in aconitase proteolysis (Fig. 2c).
Nonhydrolysable ATP analogues and AMP did not increase degra-
dation at all (Fig. 2c), which suggests that the energy of ATP
hydrolysis is used for this process. These data (Table 1 and Fig. 2c)
match the reported inhibitor/activator profile of Lon protease22,26.
Lon protease identification, purification and proteolytic activity.
We purified the mitochondrial matrix from bovine heart muscle
mitochondria and fractioned it using size-exclusion chromatogra-
phy (Fig. 3a). The maximal proteolytic activity was identified in
fraction 52, which corresponded to an Mr of roughly 600K (Fig.
3b). This value is similar to the molecular mass for Lon protease
estimated by Kuzela and Goldberg36 and slightly smaller than the
one calculated by Watabe and Kimura25. After purifying this frac-
tion further by affinity chromatography, silver staining of both the
native and the SDS–PAGE gels revealed only one main band (Fig.
4), with a subunit Mr of 108K. An antibody against Lon recognized
the purified Lon as two protein bands of roughly 100K and 80K.
After purification, the specific proteolytic activity against aconitase
increased more than 500-fold (Table 2).
The purified mitochondrial Lon protease preferentially degrad-
ed oxidized aconitase in an ATP-stimulated manner, with maximal
activity against aconitase that had been exposed to 5 mM H2O2
(Fig. 5a). EDTA was able to block the ATP stimulation but not the
ATP-independent baseline proteolysis, whereas PMSF was a potent
inhibitor of the enzyme regardless of the presence or absence of
ATP (Fig. 5b). These results (Fig. 5) clearly show the same pattern
of proteolytic stimulation and inhibition seen with mitochondrial
extracts (Fig. 2 and Table 1).
Several caveats must be considered when analysing the results
shown in Fig. 5. First, Lon protease is stimulated by ATP, not
dependent on ATP, therefore some baseline activity can be meas-
ured in the absence of any energy source. Second, all purified pro-
teins contain small amounts of damaged molecules that are pro-
duced during isolation and/or storage. Thus, even our ‘control’
aconitase samples contained small quantities of denatured protein,
which are good proteolytic substrates and artificially increase the
apparent degradation values of control samples. Last, all normal
proteins have an intrinsic proteolytic susceptibility depending on
their amino acid sequence and the proteases with which they come
into contact. It seems highly likely that aconitase is normally
degraded by Lon protease, but that aconitase oxidation greatly
facilitates this proteolysis (a viewpoint that is further supported
below).
Downregulation of Lon impairs mitochondrial proteolysis. WI-38
VA-13 human lung fibroblasts were treated with oligomorpholines
directed against the lon sequence, which produced a significant
downregulation of lon expression when compared with cells treat-
ed with control oligomorpholines (Fig. 6a). Four days after this
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Figure 2 Degradation of oxidatively-denatured aconitase during Incubation
with bovine heart muscle mitochondrial extract. Aconitase was tritium-labelled
by reductive methylation48 and exposed to increased concentrations of H2O2. In all
panels, protein degradation was measured by increases in acid-soluble radioactivity
after precipitation with trichloroacetic acid (see Methods)32. a, The oxidized sub-
strates and the untreated control (5 µg) were dialysed and then subjected to proteoly-
sis with bovine heart mitochondrial extract (200 µg) for 90 min. b, 5 µg of oxidized
aconitase (5 mM H2O2 exposure) or control aconitase were incubated with bovine
heart mitochondrial extract (200 µg) for the indicated times. Results shown in a
and b are the means and standard errors of nine independent determinations. c,
Oxidized and control aconitase proteolysis was measured in the presence of ATP,
ADP, AMP, AMP-PCP and ATP-γS, all at a final concentration of 5 mM. All results are
the means and standard errors of six independent determinations.
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treatment, Lon protein could not be detected by western blot in
cells treated with the lon antisense oligonucleotides.
We then isolated mitochondria from the cells and prepared
matrix fractions. We incubated these mitochondrial matrix fractions
with in vitro oxidized and native purified aconitase. The mitochon-
drial matrix purified from cells treated for 4 d with lon antisense
oligonucleotides had lost more than 87% of its ability to degrade
both oxidized and control aconitase (Fig. 6b). The remaining 13% of
proteolysis may have been due to a very small amount of residual
activity of Lon protease (even though we could not detect the
enzyme by western blot) or to other mitochondrial proteases, some
of which are also stimulated by ATP20.
We also examined the intracellular accumulation and degrada-
tion of aconitase in intact WI-38 VA-13 human lung fibroblasts that
had been treated with the lon antisense oligonucleotides. We detected
an increase in the amount of total aconitase protein in cells treated
with lon antisense oligonucleotides. Four days after oligonucleotide
treatment, the lon-deficient cells contained up to three times more
aconitase protein than did controls (Fig. 7a, b). To quantify the
amount of aconitase that was oxidized, we examined the protein car-
bonyl content of the cells. There was a marked increase in carbonylat-
ed aconitase in the cells treated with lon antisense oligonucleotide
(Fig. 7c), and this increase was inversely related to the decrease in
quantities of Lon and Lon activity observed in the same samples
(Fig. 6a, b).
The accumulation of aconitase protein had more complex
effects on the total enzymatic activity of aconitase inside the cells
treated with lon antisense oligonucleotide. After 2 d, aconitase
activity increased inside the lon-deficient cells (Fig. 7d), concurrent
with the increase in the amounts of native and moderately oxidized
aconitase (Fig. 7b, c). But after 4 d, the aconitase present inside the
cells treated with lon antisense oligonucleotide was already heavily
damaged (carbonylated), and its activity had decreased by twofold,
even though the cells contained at least double the total amount of
aconitase protein that they had on the second day after treatment
(Fig. 7d).
Discussion 
The essential mitochondrial Kreb’s cycle enzyme, aconitase (cit-
rate/cis-aconitate/isocitrate) contains four iron–sulphur centres
that make the enzyme especially sensitive to oxidative inactivation,
both in vitro and in vivo31,32,37–39. Oxidized mitochondrial proteins,
especially aconitase, can accumulate during oxidant stress, during
ageing and in age-related diseases40–43. We have shown here that oxi-
dized aconitase, generated by exposure to H2O2, is preferentially
degraded (as compared with a nonoxidized control) in both mito-
chondrial extracts and mitochondrial matrix fractions from beef
heart muscle.
Notably, mild oxidative modification of the protein resulted in
increased exposure of hydrophobic ‘patches’ and increased suscep-
tibility to proteolysis, even at oxidant concentrations that caused
only a minor loss of aconitase enzymatic activity. At exposure to
high concentrations of oxidant, aconitase was strongly modified,
becoming aggregated and even losing antigen-recognition sites,
and enzymatic activity was compromised more severely. But this
strongly oxidized form of the protein was a poor proteolytic sub-
strate. We propose that early recognition and selective degradation
of oxidized (hydrophobic) aconitase in the mitochondrial matrix is
important in preventing aggregation and accumulation of the
damaged protein (and probably of other oxidized mitochondrial
matrix proteins).
The matrix proteolytic activity responsible for selective degra-
dation of oxidized aconitase was strongly stimulated by ATP, mild-
ly stimulated by ADP, and unaffected by AMP or nonhydrolysable
ATP analogues. The matrix activity was strongly inhibited by
PMSF, and partially inhibited by NEM and EDTA. These character-
istics match the known activator/inhibitor profile of mammalian
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Figure 3 Elution profile of Lon protease from size-exclusion chromatogra-
phy and proteolytic activity of bovine heart mitochondrial matrix fractions.
a, Matrix fractionation. Mitochondrial matrix (~2 g of protein) prepared from bovine
heart mitochondria was separated by size-exclusion chromatography22,36. b,
Proteolytic activity in matrix fractions. Proteolytic activity was measured in each
fraction against both oxidized and control aconitase (both dialysed), in the presence
or absence of 5 mM ATP (only the four fractions with significant proteolytic activity
are shown). Results shown are the means and standard errors of six independent
determinations.
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Figure 4 Purification of mitochondrial Lon protease. The bovine heart mito-
chondrial matrix fraction with maximum proteolytic activity (fraction 52 from Fig. 3)
was dialysed overnight against the elution buffer supplemented with 0.5 mM ATP.
Potassium phosphate was added to this fraction to a final concentration of 10 mM,
and then the sample was applied to a 2-ml phosphocellulose column (P11,
Whatman) and eluted with a 0.1–0.4 M potassium phosphate gradient36. The most
active fraction was eluted with 250 mM potassium phosphate. Next, 2.5 µg of puri-
fied enzyme was loaded on a native gel and 2.5 µg was loaded on an SDS–PAGE
gel. The gels were then fixed and stained with silver. Antibodies against Lon were
used for the western blot. The gels were repeated several times with very similar
results.
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mitochondrial Lon protease23–26,36, the homologue of bacterial pro-
tease La21,27. In addition, the same proteolytic activity co-purified
with Lon protease after size-exclusion chromatography and affinity
chromatography of the mitochondrial matrix fraction, and puri-
fied Lon protease had the same activator/inhibitor profile (ATP,
PMSF and EDTA) as that seen in mitochondrial extracts and
matrix fractions.
In WI-38 VA-13 human lung fibroblasts, experimental downregu-
lation of Lon mediated by morpholino oligodeoxynucleotides direct-
ed against the lon sequence substantially decreased the intracellular
amount of Lon protein and decreased the degradation of aconitase, in
particular the selective degradation of oxidized aconitase. Although
H2O2 was not included in these experiments, growth in 19.9% oxygen
(that is, standard cell-culture conditions with 5% CO2) was sufficient
oxidative stress to cause the intracellular formation of oxidatively
modified (carbonylated) aconitase. Initially, treatment with lon
antisense oligonucleotides resulted in elevated mitochondrial
aconitase activity, but 4 d after this treatment the accumulating
aconitase protein became so severely modified (by carbonylation)
that enzymatic activity declined. We conclude that Lon protease is
essential in minimizing the aggregation and intracellular accumu-
lation of oxidized mitochondrial aconitase. Thus, in defences
against oxidized proteins in the mitochondria, Lon protease may
have a very similar role to that conducted by the proteasome in the
cell cytoplasm and nucleus1,3,4,7.
Oxidative inactivation of aconitase has been associated with
decreased life span in Drosophila40. A decline in aconitase activity
has also been described in other abnormalities, such as increased
oxidative stress caused by MnSOD deficiency41, and in several neu-
rodegenerative diseases including progressive supranuclear palsy44,
Friedreich’s ataxia45 and Huntington disease46. In yeast, loss of Lon
function results in irregularly shaped mitochondria in which the
matrix space becomes filled with electron-dense inclusion bodies,
which are thought to be aggregated mitochondrial proteins28,30. The
only mammalian system in which reduced expression of Lon pro-
tease has been reported is ageing murine muscle47, in which an
accumulation of oxidized protein aggregates occurs42. We propose
that ATP-stimulated Lon protease may be an essential component
of mitochondrial (and cellular) defences against the stress imposed
by life in an oxygen environment. By recognizing minor oxidative
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Figure 5 Purified Lon protease preferentially degrades oxidized aconitase.
a, ATP stimulation of Lon protease. Radiolabelled aconitase was treated with the
H2O2 concentrations indicated, dialysed and then subjected to degradation by Lon
protease in the absence or presence of 5 mM ATP. The variously oxidized aconi-
tase proteolytic substrates (each at 5 µg) were incubated with purified Lon pro-
tease (2 µg) in the presence or absence of ATP (5 mM) and proteolysis was meas-
ured by the increase in acid-soluble radioactivity. b, Inhibitors and activators of Lon
protease. Untreated aconitase and aconitase oxidized by exposure to 5 mM H2O2
were dialysed and then subjected to proteolysis by the purified Lon protease, as in
a. The effects of the proteolytic activator ATP (5 mM) and the inhibitors EDTA (25
mM), and PMSF (5 mM) were then tested. The values reported represent the means
and standard errors from six independent determinations.
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Figure 6 Diminished ATP-stimulated degradation of aconitase in intact WI-
38 VA-13 human fibroblasts after treatment with lon antisense oligonu-
cleotides. a, The amount of Lon protease protein decreases after treatment with
lon antisense oligonucleotides. WI-38 VA-13 human lung fibroblast cells were treat-
ed with a lon antisense morpholino oligonucleotide, or a matched control morpholi-
no oligonucleotide, and the amount of Lon protease was determined 2 and 4 d
after treatment by western blot analysis. These experiments were repeated three
times with very similar results. b, Downregulation of lon reduces aconitase proteoly-
sis in mitochondrial extracts. Mitochondrial matrix was isolated from the two
groups of cells shown in a and incubated with oxidized aconitase (5 mM H2O2 treat-
ment) or control aconitase to measure proteolytic susceptibility. The ATP concentra-
tion was 5 mM when used. All results shown are the means and standard errors of
six independent determinations.
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changes to aconitase structure and rapidly degrading the mildly
modified protein, Lon protease may prevent more extensive oxida-
tion, aggregation and accumulation, which might otherwise com-
promise mitochondrial function and cell viability. Given the large
accumulation of oxidized protein aggregates that occurs with loss
of Lon protease activity28,30,42,47, it seems likely that the oxidized
forms of several mitochondrial matrix proteins are preferred sub-
strates for the protease.
Methods 
Materials
All chemicals and reagents were obtained from Sigma unless otherwise specified. Porcine heart mito-
chondrial aconitase (A5384, Sigma) was radiolabelled by reductive methylation using [3H]formalde-
hyde (NEN)48. Radiolabelled aconitase was exposed to increasing concentrations of H202 at 37 °C and
pH 7.4 as described32, except that a shorter incubation time (30 min) was used. We dialysed both the
oxidized aconitase and the controls extensively before using them as proteolytic substrates.
Isolation of mitochondria
Bovine heart mitochondria were isolated as described49 in a homogenizing buffer (0.21 M mannitol,
70 mM sucrose, 1 mM EDTA and 5 mM HEPES, pH 7.4). 
Human WI-38 VA-13 lung fibroblasts (ATCC) were grown in Eagle’s minimum essential medium
(EMEM) supplemented with 10% fetal bovine serum, penicillin (100 units ml−1) and streptomycin
(100 µg ml−1). The cultures were grown in a humidified incubator containing 19.9% O2 and 5% CO2 at
37 °C. For isolating mitochondria, we collected 109 cells for each experiment50. The homogenizing
buffer was the same as that used for heart mitochondrial purification.
Mitochondrial pellets from both sources above were incubated with digitonin (50 µg per mg pro-
tein) to disrupt any remaining contaminating lysosomes10. Finally, mitochondria were suspended in
TMGD buffer (10 mM Tris (pH 8), 5 mM MgCl2, 1 mM dithiothreitol and 20% glycerol) and frozen at
–70 °C until used. For proteolysis assays, we ruptured the mitochondria by sonication with a VWR
sonicator (Branson 450) at maximum intensity and separated the matrix fraction by centrifugation for
1 h at 120,000g (ref. 36).
Matrix fractionation and Lon protease purification
The matrix fraction from bovine heart mitochondria was subjected to gel filtration on a XK 26/100
column (Amersham) packed with Sephacryl S-300 HR (Amersham) and equilibrated with an elution
buffer comprising 10 mM Tris-HCl (pH 7.8), 1 mM dithiothreitol, 0.5 mM EDTA and 20%
glycerol22,36. Thyroglobulin (700K), ferritin (440K), catalase (232K) and aldolase (158K) were used to
calculate the calibration curve by regression analysis. The flow rate was maintained at 1 ml min–1 and
each 2-ml fraction was collected. The column was calibrated with known marker proteins and the
fractions were assayed for their proteolytic activities against both native and oxidized aconitase. We
further purified the fraction containing the maximum proteolytic activity by phosphocellulose affinity
chromatography on a P11 column (Whatman) with a 0.1–0.4 M potassium phosphate gradient con-
taining ATP36. After this step, the enzyme preparation showed only one principal band when run on
the nondenaturing, native gels.
Aconitase degradation
Untreated and oxidatively denatured mitochondrial aconitase (5 µg) was incubated with sonicated mito-
chondria (200 µg) or purified Lon protease (2 µg) in TMGD buffer, for 90 min at 37 °C with vigorous
shaking. For experiments with purified Lon protease, we also added 200 µg of unlabelled bovine serum
albumin as a carrier. After 90 min, trichloroacetic acid was added to a final concentration of 10%, and
the tubes were incubated on ice for 30 min, followed by centrifugation at 3,000g for 15 min. The super-
natants were collected, and the pellets solubilized and neutralized in 1 N NaOH. The degradation of 3H-
labelled aconitase was monitored by the increasing production of acid-soluble radioactivity (from pre-
viously acid-insoluble aconitase protein) after precipitation with trichloroacetic acid. To calculate the
percentage of protein degradation, we used liquid scintillation counting32 to measure the acid-soluble
radioactivity relative to the initial acid-insoluble radioactivity. 
Aconitase activity
Mitochondrial aconitase activity was determined both in cell extracts and with purified aconitase
(Sigma) using the Bioxytech Aconitase-340 assay (Oxis Research), which measures the formation of
NADPH from NADP+ concomitant with the conversion of citrate to isocitrate through cis-aconitate.
We monitored the reaction at 340 nm for 5 min at 37 °C (ref. 51).
Preparation of antibodies and western analysis
The polyclonal antibody against Lon was raised in rabbits against a synthetic peptide corresponding to
amino acids 593–609 of intact human Lon protease, and it crossreacts with bovine Lon. In bovine
heart mitochondrial extracts and WI-38 VA-13 human lung fibroblast cell extracts, the polyclonal anti-
body against Lon recognized mainly one protein band with an estimated Mr of about 100K, which cor-
responds to the molecular mass reported for human and bovine Lon protease21,25,36. With purified Lon
protease a second band of Mr 80K was detected, consistent with a previously reported fragmentation
product36. 
The polyclonal antibody against aconitase was targeted to residues 767–780 of the carboxy termi-
nus of human mitochondrial aconitase and crossreacts with both porcine and bovine mitochondrial
aconitase. This antibody specifically recognized an band of 83K, corresponding to the Mr of intact
mitochondrial aconitase in whole-cell and mitochondria extracts. When oxidized aconitase (Sigma)
was used, a few fragmentation and aggregation products were also detected. ProSci produced both
antibodies.
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Figure 7 Aconitase protein quantity, activity and oxidative modification in
WI-38 VA-13 human lung fibroblasts treated with lon antisense oligonu-
cleotides. Cell extracts were prepared from WI-38 VA-13 human lung fibroblasts
exposed either to a lon antisense morpholino oligonucleotide or to a control mor-
pholino oligonucleotide for 0–4 d. Total aconitase protein was visualized using a pri-
mary polyclonal antibody against human aconitase, and carbonyl groups (oxidized
proteins) were identified using antibodies against DNP. a, Representative total
aconitase western blot. b, Summary of means and standard errors of total aconi-
tase from three different experiments in which total amounts of aconitase, visual-
ized by western blotting as in a, were quantified by densitometry and are
expressed in arbitrary units. c, Representative carbonylated aconitase western blot
detection, 2 and 4 d after treatment with morpholino oligonucleotides. d, Aconitase
activity was measured in whole-cell extracts. Results are means and standard
errors of three independent determinations.
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For western blot analysis, we loaded 25 µg of purified oxidized aconitase (Sigma), 2.5 µg of purified
Lon protease and 5 µg of cell extracts per lane. After separation, the proteins were transferred onto
BioRad PVDF membranes. The membranes were incubated with the antibody against Lon at a dilu-
tion of 1:1,000, or with the antibody against aconitase at a dilution of 1:2,000. The secondary antibody
in both cases was a goat anti-rabbit IgG (Jackson ImmunoResearch) used at a dilution of 1:20,000.
Antigens were detected by chemiluminesce with Amersham’s ECL substrates.
To detect oxidized aconitase, we used the Oxyblot kit from Intergen Company, which is based on
the derivatization of carbonyl groups in the presence of 2,4-dinitrophenylhydrazine (DNPH) and uses
a primary antibody against dinitrophenylhydrazone (DNP) moieties for detection. We loaded 10 µg of
protein in each lane. The blots were stripped and reprobed with the antibody against aconitase to con-
firm the aconitase identity.
Oligonucleotides and delivery
We used a custom (Gene Tools, LLC) antisense morpholino oligonucleotide against the lon gene to
downregulate lon in WI-38 VA-13 cells. This oligonucleotide (5′-CGTAGCCAGTGCTCGCCGC-
CATAGC-3′) is complementary to bases 31–55 of lon exon 1. A standard control sequence (5′-CCTCT-
TACCTCAGTTACAATTTATA-3′) that has no target and no significant biological activity (Gene Tools)
was also tested. Delivery was achieved by using a weakly basic delivery reagent, ethoxylated poly-
ethylenimine (EPEI). The cells were incubated in the presence of the delivery system for a total of 3 h,
as suggested by the manufacturer. The final oligonucleotide concentration in the delivery medium was
1 µM. We then removed the delivery media and grew the cells in fresh EMEM medium. The antisense
morpholino oligonucleotide system used by us has high and predictable activity inside the cell and is
immune to nucleases, which meant that only a single treatment was required52.
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